Status: Ongoing, but not recruiting participants
ClinicalTrials.gov Identifier: NCT02307682
RTH-258-C001: A two-year, randomized, Double-Masked, Multicenter, Three-Arm Study Comparing the efficacy and safety of RTH258 versus Aflibercept in subjects with Neovascular Age-Related Macular Degeneration.
Condition: Neovascular Age-Related Macular Degeneration
Study Type: Interventional
Duration: 96 Weeks
Eligibility:
For additional information on this study, please click here
Back to Clinical Research